These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. Lee SI; Atri M Radiology; 2019 Jul; 292(1):15-24. PubMed ID: 31135294 [TBL] [Abstract][Full Text] [Related]
4. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966 [TBL] [Abstract][Full Text] [Related]
5. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? Haldorsen IS; Lura N; Blaakær J; Fischerova D; Werner HMJ Curr Oncol Rep; 2019 Jul; 21(9):77. PubMed ID: 31359169 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma. Rockall AG; Barwick TD; Wilson W; Singh N; Bharwani N; Sohaib A; Nobbenhuis M; Warbey V; Miquel M; Koh DM; De Paepe KN; Martin-Hirsch P; Ghaem-Maghami S; Fotopoulou C; Stringfellow H; Sundar S; Manchanda R; Sahdev A; Hackshaw A; Cook GJ; Clin Cancer Res; 2021 Dec; 27(23):6457-6466. PubMed ID: 34526364 [TBL] [Abstract][Full Text] [Related]
7. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
8. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines). Fischerová D; Cibula D Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057 [TBL] [Abstract][Full Text] [Related]
9. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer. Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068 [TBL] [Abstract][Full Text] [Related]
13. Staging of Cervical Cancer: A Practical Approach Using MRI and FDG PET. Lakhman Y; Aherne EA; Jayaprakasam VS; Nougaret S; Reinhold C AJR Am J Roentgenol; 2023 Nov; 221(5):633-648. PubMed ID: 37459457 [TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases. Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422 [TBL] [Abstract][Full Text] [Related]
16. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy. Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Sarabhai T; Schaarschmidt BM; Wetter A; Kirchner J; Aktas B; Forsting M; Ruhlmann V; Herrmann K; Umutlu L; Grueneisen J Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions. Morkel M; Ellmann A; Warwick J; Simonds H Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535 [TBL] [Abstract][Full Text] [Related]
19. PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features. Esfahani SA; Torrado-Carvajal A; Amorim BJ; Groshar D; Domachevsky L; Bernstine H; Stein D; Gervais D; Catalano OA Mol Imaging Biol; 2022 Feb; 24(1):60-69. PubMed ID: 34622425 [TBL] [Abstract][Full Text] [Related]
20. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]